BiotechTube

OAC alone

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Atrial Fibrillation

Conditions

Atrial Fibrillation, Coronary Artery Disease

Trial Timeline

Nov 5, 2013 → May 18, 2018

NCT ID
NCT01962545

About OAC alone

OAC alone is a approved stage product being developed by Daiichi Sankyo for Atrial Fibrillation. The current trial status is completed. This product is registered under clinical trial identifier NCT01962545. Target conditions include Atrial Fibrillation, Coronary Artery Disease.

What happened to similar drugs?

20 of 20 similar drugs in Atrial Fibrillation were approved

Approved (20) Terminated (4) Active (0)
✅EdoxabanDaiichi SankyoApproved
✅Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
✅dapagliflozin + PlaceboAstraZenecaApproved
✅valsartanNovartisApproved
✅Apixaban + Parenteral heparin and/or oral Vitamin K antagonistPfizerApproved
✅Vitamin K antagonist + ApixabanPfizerApproved
✅Apixaban + aspirinPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01962545ApprovedCompleted

Competing Products

20 competing products in Atrial Fibrillation

See all competitors
ProductCompanyStageHype Score
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonistDaiichi SankyoPhase 3
40
Edoxaban + ASADaiichi SankyoPhase 3
32
DU-176b tablets + DU-176b tablets + Warfarin tabletsDaiichi SankyoPhase 2
35
Edoxaban + Apixaban + RivaroxabanDaiichi SankyoPre-clinical
26
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based RegimenDaiichi SankyoPhase 3
40
Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarinDaiichi SankyoPhase 2
35
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoApproved
43
Edoxaban + Warfarin + EnoxaparinDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b 15mg + DU-176b 30mg + DU-176b 60mgDaiichi SankyoPhase 3
40
dabigatran, rivaroxaban, apixaban or edoxabanDaiichi SankyoPre-clinical
22
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b tablets + Warfarin potassium tabletsDaiichi SankyoPhase 2
35
Edoxaban-based Regimen + VKA-based RegimenDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
39
EdoxabanDaiichi SankyoPre-clinical
26